3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
11
Burkitt Lymphoma
8
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Smoldering Multiple Myeloma
2
Lymphoma, Mantle-Cell
2
Lung Neoplasms
2
Immunoglobulin Light-chain Amyloidosis
2
Down Syndrome
2
Neoplasms
1
Neoplasm Metastasis
1
Leukemia, Plasma Cell
1
Leukemia, Biphenotypic, Acute
1
Esophageal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Brain Neoplasms
1
Ann Arbor Stage II Mantle Cell Lymphoma
1
Interventions
Cyclophosphamide
7
Specimen Handling
5
fludarabine
4
Standard of Care
4
trametinib
3
Practice Guidelines as Topic
3
Magnetic Resonance Spectroscopy
3
GSK2636771
3
Biopsy
3
venetoclax
2
talquetamab
2
osimertinib
2
dabrafenib
2
capivasertib
2
binimetinib
2
X-Rays
2
Thiotepa
2
Tacrolimus
2
Patient Navigation
2
Nivolumab
2
Mycophenolic Acid
2
Methods
2
Mesna
2
Melphalan
2
Filgrastim
2
Educational Status
2
Early Intervention, Educational
2
Crizotinib
2
Ado-Trastuzumab Emtansine
2
2-(3-(2-(1-isopropyl-3-methyl-1H-1,2-4-triazol-5-yl)-5,6-dihydrobenzo(f)imidazo(1,2-d)(1,4)oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hematologic Neoplasms
×
dexamethasone acetate
×
30 days
×
Clear all
No trials found.